Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Psychedelics Business

News
Field Trip Health & Wellness Seeks Buyer, Announces CEO Resignation
03/24/2023
After recently disclosing plans to close 5 of its psychedelic-assisted psychotherapy treatment program locations, Field Trip Health & Wellness intends to conduct an expedited sale of its business. Chairman and CEO Ronan Levy has resigned.
After recently disclosing plans to close 5 of its psychedelic-assisted psychotherapy treatment program locations, Field Trip Health & Wellness intends to conduct an expedited sale of its business. Chairman and CEO Ronan Levy has resigned.
After recently disclosing plans...
03/24/2023
Behavioral Healthcare Executive
News
Psychedelics Business Briefs: Numinus, Delix, Irwin Naturals
02/23/2023
Numinus Wellness has added a clinical research site in Arizona, Delix Therapeutics has announced 2 new partnerships, and Irwin Naturals has completed its acquisition of Serenity Health in Kentucky.
Numinus Wellness has added a clinical research site in Arizona, Delix Therapeutics has announced 2 new partnerships, and Irwin Naturals has completed its acquisition of Serenity Health in Kentucky.
Numinus Wellness has added a...
02/23/2023
Behavioral Healthcare Executive
News
Psychedelic Business Briefs: Choose Ketamine, SABI Mind, Cybin
02/07/2023
Choose Ketamine has completed a seed funding round, SABI Mind has received regulatory approval to launch a psilocybin study to treat alcohol use disorder, and Cybin has been approved to begin a Phase 1 trial studying its proprietary DMT...
Choose Ketamine has completed a seed funding round, SABI Mind has received regulatory approval to launch a psilocybin study to treat alcohol use disorder, and Cybin has been approved to begin a Phase 1 trial studying its proprietary DMT...
Choose Ketamine has completed a...
02/07/2023
Behavioral Healthcare Executive
BHE Psychedelics Podcast
BHE Podcast
BHE Psychedelics Podcast, Episode 005 — Revitalist Lifestyle and Wellness CEO Kathryn Walker, APRN, CRNA, PMHNPS
12/26/2022
Revitalist Lifestyle and Wellness CEO Kathryn Walker, APRN, CRNA, PMHNPS, a presenter at the recent Treatment Center Investment & Valuation Retreat, discusses the potential uses for psychedelics in behavioral healthcare.
Revitalist Lifestyle and Wellness CEO Kathryn Walker, APRN, CRNA, PMHNPS, a presenter at the recent Treatment Center Investment & Valuation Retreat, discusses the potential uses for psychedelics in behavioral healthcare.
Revitalist Lifestyle and...
12/26/2022
Behavioral Healthcare Executive
News
Business Briefs: Ochsner Lafayette General, Oceans Healthcare, Children’s Minnesota, Thrive Healthcare, Harmony Recovery Group, Reverie Mind
11/25/2022
Ochsner Lafayette General and Oceans Healthcare are building a facility in Louisiana, Children’s Minnesota is launching an inpatient unit, Thrive Healthcare has acquired Harmony Recovery Group, and Reverie Mind is acquiring Arizona Ketamine...
Ochsner Lafayette General and Oceans Healthcare are building a facility in Louisiana, Children’s Minnesota is launching an inpatient unit, Thrive Healthcare has acquired Harmony Recovery Group, and Reverie Mind is acquiring Arizona Ketamine...
Ochsner Lafayette General and...
11/25/2022
Behavioral Healthcare Executive
News
Psychedelic Business Briefs: Numinus, Better U, Supermind
11/03/2022
Numinus Wellness launched a new ketamine program, Better U is expanding its telemedicine platform, and tech firm Supermind Platforms has closed a pre-seed financing round.
Numinus Wellness launched a new ketamine program, Better U is expanding its telemedicine platform, and tech firm Supermind Platforms has closed a pre-seed financing round.
Numinus Wellness launched a new...
11/03/2022
Behavioral Healthcare Executive
News
Psychedelics Business Briefs: Delix, Numinus, Ketamine Wellness Centers
09/23/2022
Delix Therapeutics has named its first head of research and development. Numinus Wellness has opened a new clinic in downtown Montreal. And Ketamine Wellness Centers has expanded a partnership with the Veteran Administration Community Care...
Delix Therapeutics has named its first head of research and development. Numinus Wellness has opened a new clinic in downtown Montreal. And Ketamine Wellness Centers has expanded a partnership with the Veteran Administration Community Care...
Delix Therapeutics has named its...
09/23/2022
Behavioral Healthcare Executive
News
Psychedelics Briefs: Awakn Life Sciences, Numinus Wellness, Revitalist, Wake Network
09/15/2022
Awakn has partnered with Catalent to use the latter’s orally disintegrating tablet in its MDMA program, Numinus Wellness has had an active quarter, and Revitalist and Wake Network are launching a psilocybin retreat program for vets.
Awakn has partnered with Catalent to use the latter’s orally disintegrating tablet in its MDMA program, Numinus Wellness has had an active quarter, and Revitalist and Wake Network are launching a psilocybin retreat program for vets.
Awakn has partnered with...
09/15/2022
Behavioral Healthcare Executive
News
Psychedelics Briefs: Freedom Biosciences, Awakn, Revitalist
08/25/2022
Freedom Biosciences has emerged from stealth with $10.5 million in seed financing. Awakn Life Sciences has signed a licensing deal that will allow Revitalist Lifestyle and Wellness to use Awakn’s ketamine-assisted therapy to treat its clients...
Freedom Biosciences has emerged from stealth with $10.5 million in seed financing. Awakn Life Sciences has signed a licensing deal that will allow Revitalist Lifestyle and Wellness to use Awakn’s ketamine-assisted therapy to treat its clients...
Freedom Biosciences has emerged...
08/25/2022
Behavioral Healthcare Executive
News
Psychedelics Briefs: Numinus Wellness, MAPS Public Benefit Corporation
06/29/2022
Numinus Wellness has announced a corporate ketamine-assisted therapy pilot, while MAPS Public Benefit Corp. has selected a contract research organization for the development of a new drug application for MDMA-assisted therapy for PTSD.
Numinus Wellness has announced a corporate ketamine-assisted therapy pilot, while MAPS Public Benefit Corp. has selected a contract research organization for the development of a new drug application for MDMA-assisted therapy for PTSD.
Numinus Wellness has announced a...
06/29/2022
Behavioral Healthcare Executive

Advertisement

Advertisement

Browse Our Other Brands

Psych NP Institute

 

Psych Congress Network

 

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement